Skip to main content
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance
  • News article
  • 1 August 2014
  • European Medicines Agency
  • 1 min read

New PROTECT benefit-risk website

The Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium (PROTECT) contains a number of work programmes whose goal is to strengthen the benefit-risk monitoring of medicines in Europe. Work program 5 (Benefit-Risk group) of PROTECT has developed a new website on available methods for benefit-risk evaluation and representation. It includes supporting tools and recommendations for use of benefit-risk methodologies and intends to be a guide for readers who are new to the world of benefit-risk assessment.

Related information:

» PROTECT benefit-risk website

» PROTECT project

Details

Publication date
1 August 2014
Author
European Medicines Agency